Leveraging chemotherapy-induced lymphopenia to potentiate cancer immunotherapy

First-line chemotherapy to combat primary malignant brain cancer is often accompanied by lymphopenic immunologic deficiency. Although counterintuitive, chemotherapy-induced lymphopenia can provide excellent host conditioning that may actually be leveraged to potentiate antitumor immunotherapy. We di...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncoimmunology
Glavni autori: Sanchez-Perez, Luis, Suryadevara, Carter M, Choi, Bryan D, Reap, Elizabeth A, Sampson, John H
Format: Artigo
Jezik:Inglês
Izdano: Taylor & Francis 2014
Teme:
Author's View
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4292586/
https://ncbi.nlm.nih.gov/pubmed/25610727
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/21624011.2014.944054
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items